What is the Mediterranean fever?
People can use the term "Mediterranean fever" to indicate two different and unrelated health conditions. The first is a genetic disorder known as familial Mediterranean fever, which is most commonly observed in populations around the Mediterranean. This term is also used to describe brucelosis, a bacterial infection that can be observed in many Mediterranean populations. Although both states are associated with the Mediterranean region and both cause fever, they are caused and treated very differently.
In the case of familial Mediterranean fever, disease is inherited. It is recessive, which requires people inherit a copy of a defective gene from both parents to develop this disease, and usually in childhood, with people experiencing episodes in their youth. The diagnosis depends on symptoms, publication of family history and medical tests to exclude other potential causes.Gh fever. In approximately three -quarters of patients, symptoms such as joint, stomach and chest pain develop during attacks. Episodes of usualLE performs their course without intervention, but some patients benefit from analgesic drugs to solve pain as well as anti -inflammatory drugs to reduce inflammation associated with the disease.
A drug known as cholchicin is used in the treatment of familial Mediterranean fever. This drug can act as prophylactic if it is taken from the attack to prevent the next round of fever and other symptoms. Patients who learn to recognize the warning signals may take a peribetic dose to turn off inflammation before it is started.
Brucelosis is a zoonotic bacterial disease, contractual eating contaminated meat and milk from animals. People with this disease develop high fever, dizziness, confusion, weakness and muscle pain. Disease may be treated with antibiotics and a long course is required because bacteria incubate inside the body cells. If the course is shortened, they may reappear and cause another round of infectione.
In patients with brucelosis, it is very important to observe the medication regime, although the drugs will need to be taken long after they feel as if the infection has ended. This will reduce the development of antibiotics resistance and also ensure that incubation bacteria do not have the opportunity to revive the patient. The transfer of a person to a person is rare and is safe to take care of people with brucelosis without having to take care of picking up bacteria.